The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring

Hum Immunol. 1990 Nov;29(3):229-32. doi: 10.1016/0198-8859(90)90117-8.

Abstract

Nineteen patients that had developed hypertrophic scars subsequent to thermal injury were typed for HLA class II allogenotypes with the restriction fragment length polymorphism technique. A significant association was found with DR beta 16 (pc = 1.45 x 10(-4); relative risk = 12.25). This finding adds evidence to other data suggesting that immunologic phenomena are involved in pathologic scarring. Moreover, the results presented here have allowed an identification of a genetically determined risk factor for hypertrophic scar formation located in the HLA region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cicatrix / genetics
  • Cicatrix / immunology*
  • Genotype
  • HLA-DQ Antigens / genetics
  • HLA-DR Antigens / genetics
  • HLA-DR Antigens / physiology*
  • HLA-DR Serological Subtypes
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Testing
  • Humans
  • Isoantigens / physiology
  • Polymorphism, Restriction Fragment Length
  • Risk Factors
  • Wound Healing / immunology*

Substances

  • HLA-DQ Antigens
  • HLA-DR Antigens
  • HLA-DR Serological Subtypes
  • HLA-DR16 antigen
  • Histocompatibility Antigens Class II
  • Isoantigens